Grifols to acquire Talecris

Grifols S.A. (Madrid:GRF) plans to acquire fellow plasma protein company Talecris Biotherapeutics Inc. (NASDAQ:TLCR) in a cash and stock

Read the full 196 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE